multi-array® 96-well assay plate (Meso Scale Diagnostics LLC)
90
Structured Review
Meso Scale Diagnostics LLC
multi-array® 96-well assay plate
Multi Array® 96 Well Assay Plate, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi-array+96-well+plate/96+well+plates/us12216117-404-7-15
Average 90 stars, based on 1 article reviews
Multi Array® 96 Well Assay Plate, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi-array+96-well+plate/96+well+plates/us12216117-404-7-15
Average 90 stars, based on 1 article reviews
multi-array® 96-well assay plate - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Antibodies that bind TNFRSF25 Article Snippet: To detect binding of the antibodies to human TNFRSF25, recombinant biotin-conjugated human TNFRSF25 protein was immobilized onto a Article Title: An ANGPTL4 inhibitory antibody safely improves lipid profiles in non-human primates Article Snippet: In parallel, a 384-well streptavidin-coated Article Title: Evaluation of HPV-loaded PLGA microparticles as single-dose HPV vaccine: Insights for sustained-release vaccine development. Article Snippet: The human papillomavirus (HPV) vaccine is pivotal to prevent new HPV infections and associated diseases globally, which requires a multi-dose regimen to maximize protection.. A long-acting HPV vaccine that can be administered in a single immunization during a doctor’s visit would be highly desirable if comparable benefits are provided to that of standard of care (SoC).. This work explored the development of a sustained-release HPV vaccine formulation via temperature-programmed loading of polylactic-co-glycolic acid (PLGA) microparticles (MPs). Article Title: Short-Term Immunosuppression in Rats Induces Prolonged Immune Tolerance Towards a Human Monoclonal Antibody, Erenumab. Article Snippet: A standard 96-well streptavidin coated MSD plates ( Article Title: Differential pathological dynamics triggered by distinct Parkinson patient–derived α-synuclein extracts in nonhuman primates Article Snippet: The capture antibody MJFR1 (3 μl/ml; Abcam, Cambridge, UK) was coated onto Article Title: Antitumor Cytotoxic Activity Retained in Tolerized T Cells Following Daily Dose Escalation of a T-Cell Engager in Cynomolgus Monkeys to Mitigate Cytokine Release Syndrome. Article Snippet: Tcell engagers demonstrate promise in cancer immunotherapy but often cause severe cytokine release syndrome (CRS).. Intrapatient dose escalation can mitigate CRS, but reduced cytokine levels may compromise therapeutic efficacy.. We previously reported that a single 1000 μg/kg dose of ERY22, an antiGPC3/CD3 monkey surrogate Tcell engager, induces lifethreatening CRS in cynomolgus monkeys, but that daily dose escalation from 1 to 1000 μg/kg almost completely prevented CRS in the monkeys without premedication with immunosuppressants. Article Title: Short-Term Immunosuppression in Rats Induces Prolonged Immune Tolerance Towards a Human Monoclonal Antibody, Erenumab. Article Snippet: Generated:Article Title: Target tolerance improvement of the immunogenicity assay developed for analysing samples from clinical trials of RGB-14, a proposed biosimilar to Prolia/Xgeva. Article Snippet: An immunogenicity assay was developed to support the clinical program of RGB-14, a proposed biosimilar to Prolia/Xgeva.. The ADA assay was successfully validated following current guidelines and white papers.. The validation included an assessment of target (RANKL) interference, and the assay passed the test up to a 30 pg/mL RANKL level. |